Healthlead PCL (BKK:HL) Total Operating Expense: ฿440 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:HL Healthlead PCL BKK:HL
76 GF Score
Price ฿5.80
GF Value ฿10.89
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Healthlead PCL Total Operating Expense?

Healthlead PCL BKK:HL 76 Total Operating Expense is ฿440 Mil as of Mar. 2026. GuruFocus rates BKK:HL with a GF Score™ of 76/100 and a GF Value™ of ฿10.89 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Healthlead PCL's Total Operating Expense for the three months ended in Mar. 2026 was ฿112 Mil. Healthlead PCL's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ฿440 Mil.

Healthlead PCL Total Operating Expense Related Terms

Healthlead PCL Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Healthlead PCL's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthlead PCL Total Operating Expense Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 173.70 227.86 276.49 369.36 431.85

Healthlead PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.99 109.38 108.54 109.94 112.29
BKK:HL
76GF Score
Healthlead PCL BKK:HL
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthlead PCL Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿440 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ฿440 Mil mean?
Healthlead PCL (BKK:HL) has a Total Operating Expense of ฿440 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Healthlead PCL and its competitors.
Is Healthlead PCL's Total Operating Expense too high?
Healthlead PCL's current Total Operating Expense is ฿440 Mil. Overall, Healthlead PCL has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Total Operating Expense compare to competitors?
Healthlead PCL's Total Operating Expense of ฿440 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Healthlead PCL and its competitors. Healthlead PCL's current Total Operating Expense is ฿440 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿10.89, compared to a current price of ฿5.80 — trading 46.7% below its estimated fair value. The current Total Operating Expense is ฿440 Mil. Healthlead PCL's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Total Operating Expense is ฿440 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthlead PCL (BKK:HL) Overvalued in 2026?

Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued. The current stock price of ฿5.80 is trading 46.7% below its estimated GF Value™ of ฿10.89. GuruFocus considers Healthlead PCL to be Significantly Undervalued.

Key valuation signals for BKK:HL:

  • Total Operating Expense: ฿440 Mil
  • GF Value™: ฿10.89 vs. price of ฿5.80 (46.7% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthlead PCL Business Description

Address 99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
76GF Score

Get the complete analysis for BKK:HL

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.80
Price
฿10.89
GF Value